Short interest in Enlivex Therapeutics Ltd (NASDAQ:ENLV) increased during the last reporting period, rising from 100.87K to 160.14K. This put 0.79% of the company's publicly available shares short.

Short interest for Enlivex Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Enlivex Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 211.91K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.